American Society for Neural Therapy and Repair/International Conference on Neural

美国神经治疗与修复学会/国际神经会议

基本信息

  • 批准号:
    8129235
  • 负责人:
  • 金额:
    $ 2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-04-01 至 2012-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This R13 application seeks funding to support travel awards for students and postdoctoral fellows to attend the joint meeting of the American Society for Neural Therapy and Repair (ASNTR) and the International Conference on Neural Therapy and Repair (INTR) to be held May 4 - May 8, 2011. Since its founding in 1994, the ASNTR has convened yearly each April/May in Clearwater, Florida. This year the meeting has merged with the 11th convening of the INTR which meets every three years alternating between the US, Asia and Europe. Both societies have a strong tradition of focusing on research advances in the fields of transplantation, neuroengineering and gene therapy applied to neurological diseases such as Parkinson's disease, Huntington's disease, Alzheimer's disease, stroke, spinal cord injury and traumatic brain injury that may lead to novel treatment strategies. Clinical trials that have emerged from basic science research reported on at previous meetings are often presented. Thus, students and postdoctoral fellows not only learn the basic sciences, they also learn translational issues discussed between basic scientists and clinicians. Therefore, ASNTR/INTR are truly unique gatherings. Attendance of this meeting is projected to be approximately 250- 300 registrants, based on previous participation levels. Each year the ASNTR Education and Training Committee encourages students/postdoctoral fellows to submit their abstracts in a competition and the top rated applicants receive travel awards to cover the cost of their meeting attendance and travel. ASNTR has always placed a high priority on funding travel awards for students and post-doctoral fellows. In the past ASNTR has received donations from biotech companies and non-profit organizations to cover these travel awards. However, in recent years ASNTR has seen these contributions dwindle and although ASNTR will continue to seek funding from the private sector, we do not anticipate any increase in contributions above recent levels in the coming years. This application requests $20,000 in total direct costs to support travel awards for the top 20 graduate students/postdoctoral fellows from US institutions that apply (awards of $1000 per student/postdoc). The ASNTR and the Education and Training Committee include and encourage participation of women, minorities and persons with disabilities in all its activities. PUBLIC HEALTH RELEVANCE: This application seeks funding for travel awards for graduate students and postdocs to attend the upcoming combined meeting of the American Society for Neural Therapy and Repair and the International Conference on Neural Therapy and Repair. This meeting will allow junior and senior scientists and doctors working to discover new treatments for neurological disorders to come together and discuss their new research findings. This meeting will potentially allow new research collaborations to occur that could lead to improved treatments for neurological disorders.
描述(由申请人提供):此R13申请寻求资金支持学生和博士后研究员的旅行奖,以参加美国神经治疗与维修学会(ASNTR)的联合会议(ASNTR)和国际神经治疗和修复会议(INTR)将于2011年5月4日至5月8日举行。自1994年成立于1994年。今年,会议与INT的第11届召集融合了一次,在美国,亚洲和欧洲之间每三年交替开会。这两个社会都有强大的传统,专注于在移植,神经工程和基因疗法领域的研究进展,适用于诸如帕金森氏病,亨廷顿氏病,阿尔茨海默氏病,中风,脊髓损伤和可能导致新型治疗策略的神经系统疾病。经常提出从先前会议上报道的基础科学研究中出现的临床试验。因此,学生和博士后研究员不仅学习了基本科学,而且还学习了基础科学家和临床医生之间讨论的翻译问题。因此,ASNTR/INT是真正独特的聚会。根据先前的参与水平,这次会议的出席预计约为250-300名注册人。每年,ASNTR教育和培训委员会都会鼓励学生/博士后研究员在比赛中提交摘要,最高评价的申请人获得旅行奖,以支付其会议出勤率和旅行费用。 ASNTR始终为学生和博士后研究员的资助旅行奖优先考虑。过去,ASNTR收到了生物技术公司和非营利组织的捐款,以涵盖这些旅行奖。但是,近年来,ASNTR看到这些贡献减少了,尽管ASNTR将继续向私营部门寻求资金,但我们预计在未来几年的贡献中不会有任何贡献的增加。该申请要求提供20,000美元的直接成本,以支持适用的美国机构的前20名研究生/博士后研究员的旅行奖(每名学生/博士后奖励$ 1000)。 ASNTR和教育和培训委员会包括并鼓励妇女,少数民族和残疾人参与其所有活动。 公共卫生相关性:该申请为研究生和博士后的旅行奖寻求资助,以参加即将举行的美国神经治疗与维修学会的合并会议以及神经治疗与维修国际会议。这次会议将允许初级和高级科学家和医生努力发现有关神经系统疾病的新疗法,并讨论他们的新研究结果。这次会议可能会允许进行新的研究合作,从而改善神经系统疾病的治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Caryl E Sortwell其他文献

Caryl E Sortwell的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Caryl E Sortwell', 18)}}的其他基金

STN DBS Effects on Neuroinflammation and Degeneration Induced by Alpha-Synuclein Inclusions
STN DBS 对 α-突触核蛋白包涵体诱导的神经炎症和变性的影响
  • 批准号:
    10355915
  • 财政年份:
    2021
  • 资助金额:
    $ 2万
  • 项目类别:
The Rat Pre-Formed Alpha-Synuclein Fibril Model of Parkinson's Disease
帕金森病大鼠预制α-突触核蛋白原纤维模型
  • 批准号:
    9751424
  • 财政年份:
    2018
  • 资助金额:
    $ 2万
  • 项目类别:
The Rat Pre-Formed Alpha-Synuclein Fibril Model of Parkinson's Disease
帕金森病大鼠预制α-突触核蛋白原纤维模型
  • 批准号:
    9387180
  • 财政年份:
    2017
  • 资助金额:
    $ 2万
  • 项目类别:
American Society for Neural Therapy and Repair
美国神经治疗与修复学会
  • 批准号:
    7672655
  • 财政年份:
    2009
  • 资助金额:
    $ 2万
  • 项目类别:
Pleiotrophin Overexpression to Facilitate Repair and Graft Efficacy in Parkinsoni
多效蛋白过度表达促进帕金森病的修复和移植功效
  • 批准号:
    7447803
  • 财政年份:
    2007
  • 资助金额:
    $ 2万
  • 项目类别:
Pleiotrophin Overexpression to Facilitate Repair and Graft Efficacy in Parkinsoni
多效蛋白过度表达促进帕金森病的修复和移植功效
  • 批准号:
    7799276
  • 财政年份:
    2007
  • 资助金额:
    $ 2万
  • 项目类别:
Pleiotrophin Overexpression to Facilitate Repair and Graft Efficacy in Parkinsoni
多效蛋白过度表达促进帕金森病的修复和移植功效
  • 批准号:
    7246907
  • 财政年份:
    2007
  • 资助金额:
    $ 2万
  • 项目类别:
Pleiotrophin Overexpression to Facilitate Repair and Graft Efficacy in Parkinsoni
多效蛋白过度表达促进帕金森病的修复和移植功效
  • 批准号:
    8070414
  • 财政年份:
    2007
  • 资助金额:
    $ 2万
  • 项目类别:
Pleiotrophin Overexpression to Facilitate Repair and Graft Efficacy in Parkinsoni
多效蛋白过度表达促进帕金森病的修复和移植功效
  • 批准号:
    7591042
  • 财政年份:
    2007
  • 资助金额:
    $ 2万
  • 项目类别:
American Society for Neural Therapy and Repair
美国神经治疗与修复学会
  • 批准号:
    7114515
  • 财政年份:
    2006
  • 资助金额:
    $ 2万
  • 项目类别:

相似国自然基金

多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
  • 批准号:
    82373667
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
恒星模型中氧元素丰度的变化对大样本F、G、K矮星年龄测定的影响
  • 批准号:
    12303035
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
基于年龄和空间的非随机混合对性传播感染影响的建模与研究
  • 批准号:
    12301629
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
  • 批准号:
    82304205
  • 批准年份:
    2023
  • 资助金额:
    20 万元
  • 项目类别:
    青年科学基金项目
中国东部地区大气颗粒物的年龄分布特征及其影响因素的模拟研究
  • 批准号:
    42305193
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
  • 批准号:
    10748606
  • 财政年份:
    2024
  • 资助金额:
    $ 2万
  • 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
  • 批准号:
    10749539
  • 财政年份:
    2024
  • 资助金额:
    $ 2万
  • 项目类别:
Understanding the Mechanisms and Consequences of Basement Membrane Aging in Vivo
了解体内基底膜老化的机制和后果
  • 批准号:
    10465010
  • 财政年份:
    2023
  • 资助金额:
    $ 2万
  • 项目类别:
Safety and Tolerability of TASIS-Peanut (Targeted Allergen Specific Immunotherapy within the Skin) patch for the Treatment of Peanut Allergy
TASIS-花生(皮肤内靶向过敏原特异性免疫疗法)贴剂治疗花生过敏的安全性和耐受性
  • 批准号:
    10551184
  • 财政年份:
    2023
  • 资助金额:
    $ 2万
  • 项目类别:
Sustained eIF5A hypusination at the core of brain metabolic dysfunction in TDP-43 proteinopathies
持续的 eIF5A 抑制是 TDP-43 蛋白病脑代谢功能障碍的核心
  • 批准号:
    10557547
  • 财政年份:
    2023
  • 资助金额:
    $ 2万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了